跳到正文
Rohan Paul· @rohanpaul_ai · X·· 2026-09-02AI 评分43
AI 导读

Apodex 发布专有模型 Apodex 1.1,在 Artificial Analysis Intelligence Index 上得 44 分,但在衡量真实世界智能体工作的 GDPval-AA v2 上达到 1,348 Elo,超过多个通用智能分数更高的模型。

正文 · 原文

Apodex released Apodex 1.1, its proprietary model that reached 44 on the Artificial Analysis Intelligence Index and performs strongly on agentic tasks versus models in its tier.

on GDPval-AA v2, which measures real-world agentic work, it reaches 1,348 Elo, ahead of several models with much higher general intelligence scores.

So Apodex 1.1, its performance seems concentrated around professional and agentic tasks rather than being evenly distributed across the evaluation suite.

I increasingly think this distinction matters for model selection. A model that wins broad reasoning benchmarks is not automatically the model you want sitting inside an agentic execution loop.

For agents, the relevant question is: once you give the model a goal and tools, how often does it actually get the job done?

Apodex 1.1 from @Apodex_AI looks unusually concentrated in that direction.

引用Apodex@Apodex_AI
We invite you to read the full TRACES technical report Inside: the definitions, evaluation rubric, and registry of problems spanning biomedicine, clinical translation, and frontier-model engineering. Led by Apodex Lead Scientist @profshengwang, the report brings together the technical framework underpinning this effort. Behind it: 10 STEM PhDs, two months of research, and 561 industries surveyed to identify 423 problems worth solving—real, high-stakes questions that can take human experts years to work through. Bring a problem. Bring a solver. Both doors are open. *Submit a Problem: https://traces.apodex.com/submit-your-problem *Submit a Solver: https://traces.apodex.com/submit-your-solver
在 X 查看被引用的帖子

来源:Rohan Paul · x.com